CARBAMAZEPINE and PYREXIA

Overview

PYREXIA is the #6 most commonly reported adverse reaction for CARBAMAZEPINE, manufactured by Novartis Pharmaceuticals Corporation. There are 2,690 FDA adverse event reports linking CARBAMAZEPINE to PYREXIA. This represents approximately 2.2% of all 124,512 adverse event reports for this drug.

Patients taking CARBAMAZEPINE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for CARBAMAZEPINE, but still significant enough to appear in the safety profile.

Other Side Effects of CARBAMAZEPINE

In addition to pyrexia, the following adverse reactions have been reported for CARBAMAZEPINE:

• DRUG INEFFECTIVE — 4,900 reports
• SEIZURE — 3,609 reports
• DRUG INTERACTION — 3,371 reports
• FALL — 3,046 reports
• DIZZINESS — 2,860 reports
• NAUSEA — 2,629 reports
• TOXICITY TO VARIOUS AGENTS — 2,599 reports
• OFF LABEL USE — 2,587 reports
• VOMITING — 2,504 reports
• CONVULSION — 2,502 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does CARBAMAZEPINE cause PYREXIA?

PYREXIA has been reported as an adverse event in 2,690 FDA reports for CARBAMAZEPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with CARBAMAZEPINE?

PYREXIA accounts for approximately 2.2% of all adverse event reports for CARBAMAZEPINE, making it a notable side effect.

What should I do if I experience PYREXIA while taking CARBAMAZEPINE?

If you experience pyrexia while taking CARBAMAZEPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages